Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000807137 | SCV000947176 | likely benign | Duchenne muscular dystrophy | 2024-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004994026 | SCV005566500 | uncertain significance | Cardiovascular phenotype | 2024-09-30 | criteria provided, single submitter | clinical testing | The p.I2968T variant (also known as c.8903T>C), located in coding exon 59 of the DMD gene, results from a T to C substitution at nucleotide position 8903. The isoleucine at codon 2968 is replaced by threonine, an amino acid with similar properties. Based on data from gnomAD, the C allele has an overall frequency of <0.01% (2/X179863) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was <0.01% (2/79816) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |
Natera, |
RCV001830761 | SCV002080222 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-03-25 | no assertion criteria provided | clinical testing |